Elie Dolgin, PHD, Science Journalist
Eli Dolgin, PHD, Science Journalist

Science journalist

Elie Dolgin, PhD, is a freelance science journalist who specializes in biomedical research and drug discovery.

Elie Dolgin is a science journalist who splits his time between rural Vermont and urban Massachusetts. He holds a bachelor's degree in biology from McGill University and a PhD in evolutionary genetics from the University of Edinburgh. A former news editor at STAT, Nature Medicine and The Scientist, Elie has also written for publications including the New York Times, Newsweek and Science magazine.


His 2021 feature article for Nature, "The tangled history of mRNA vaccines," gained significant recognition and was referenced widely in the scientific literature, in national newspaper stories and by award selection committees.

Recent Projects

Heart cockle
By Elie Dolgin November 19, 2024
The first example of fiber optics in nature could light the way for internet innovation.
Woman's face with visor-style sunglasses shining light into her blue eyes.
By Elie Dolgin October 2, 2024
Pulses of light and sound seem to have beneficial effects. But some argue it is too soon to market experimental devices.
Image of brain inside a head
By Elie Dolgin September 26, 2024
The medication is the first in decades to have a different mode of action than do current drugs, achieving better symptom relief with fewer side effects.
A participant holds his hand in a bucket of ice while Yingzi Lin monitors his pain response.
By Elie Dolgin September 25, 2024
Pain is defined subjectively, but an objective measure of the experience promises to transform its management.
Craig Ramirez and Andrew Hauser drinking beers in a pub.
By Elie Dolgin July 11, 2024
Joining a drug candidate to a protein that malignant cells naturally take up allowed one firm to come up with a potent anti-cancer therapy.
Gloved hand handling containers of radioactive drug.
By Elie Dolgin June 13, 2024
The tumor-seeking radiopharmaceuticals are charting a new course in oncology, with promise for targeted treatments with fewer side effects.
By Elie Dolgin June 11, 2024
Moderna employees build RNA vaccines tailored to an individual’s tumour at a facility in Norwood, Massachusetts.
Kids getting an eye exam
By Elie Dolgin May 29, 2024
Time spent outdoors is the best defence against rising rates of short-sightedness, but scientists are searching for other ways to reverse the troubling trend.
Medical staffers view a computer screen showing the inside of a narrowed artery.
By Elie Dolgin May 15, 2024
The new fiber-optic probe could transform aneurysm and brain clot treatments
Show More
Share by: